Principal Investigators

    Arenas Ernest


    Karolinska Institute

    Contact information of lead PI



    Title of project or programme

    Drug discovery and regeneration for Parkinson's disease

    Source of funding information

    Swedish Foundation for Strategic Research

    Total sum awarded (Euro)

    € 1,088,139

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Parkinson's disease & PD-related disorders


    Research Abstract

    Parkinson’s disease (PD) is a progressive degenerative disorder that affects midbrain dopamine (mDA) neurons resulting in the classical motor symptoms of the disease. Currently available treatments are symptomatic and do not change the course of disease. In this project we propose to develop two novel therapeutic approaches aiming at changing the course of PD: (1) Develop drugs that target proteins mutated in genetic forms of PD, such as LRRK2, or Wnt signaling (recently linked to PD by our lab and others); (2) Develop a novel cell replacement therapy (CRT) approach based on the direct reprogramming astrocytes into mDA neurons. In this project we will thus blend novel and well established techniques, such as cellular reprogramming and chemical biology, with our expertise in stem/regenerative medicine, DA neuron development, Wnt signaling and PD. Project plan: 1) Identify/develop novel modulators of Wnt signaling to be tested in in vitro models of PD. 2) Develop an in vitro model of PD by exposing human DA neurons from PD-iPS cells, to abnormal levels of Wnt/b-catenin or small molecules. 3) Identify compounds and develop drugs to treat PD by performing a small molecule screen and using medicinal chemistry to develop leads into drugs and tested them in animal models of PD. 4) Develop novel methods for PD CRT by direct reprogramming of astrocytes into mDA neurons both in vitro and in animal models of PD. Our final goal is to develop novel effective therapies for PD.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Sweden
Diseases: Parkinson's disease & PD-related disorders
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF